
1. malar j. 2017 jan 13;16(1):28. doi: 10.1186/s12936-016-1672-0.

profile molecular mutations pfdhfr, pfdhps, pfmdr1, pfcrt genes of
plasmodium falciparum related resistance different anti-malarial drugs in
the bata district (equatorial guinea).

berzosa p(1)(2), esteban-cantos a(3), garcía l(3)(4), gonzález v(3)(4), navarro
m(3), fernández t(3), romay-barja m(3)(4), herrador z(3), rubio jm(5), ncogo
p(3)(6), santana-morales m(7), valladares b(4)(7), riloha m(6), benito a(3)(4).

author information: 
(1)malaria laboratory, national centre tropical medicine, institute health 
carlos iii, c/monforte de lemos 5, 28029, madrid, spain. pberzosa@isciii.es.
(2)network collaborative research tropical diseases, ricet, madrid, spain.
pberzosa@isciii.es.
(3)malaria laboratory, national centre tropical medicine, institute health 
carlos iii, c/monforte de lemos 5, 28029, madrid, spain.
(4)network collaborative research tropical diseases, ricet, madrid, spain.
(5)national centre microbiology, institute health carlos iii, madrid,
spain.
(6)ministry health social welfare equatorial guinea, malabo, equatorial
guinea.
(7)instituto universitario de enfermedades tropicales salud pública de
canarias, universidad de la laguna, tenerife, spain.

background: emergence drug resistance plasmodium falciparum 
major contributor global burden malaria. drug resistance complicates
treatment, one important problems malaria control. 
study assessed level mutations p. falciparum genes, pfdhfr, pfdhps,
pfmdr1, pfcrt, related resistance different anti-malarial drugs, the
continental region equatorial guinea, 8 years implementing artesunate
combination therapies first-line treatment.
results: triple mutant pfdhfr (51i/59r/108n), conferred resistance 
sulfadoxine/pyrimethamine (sp), found 78% samples rural settings; 
its frequency significantly different urban rural settings
(p = 0.007). 164l mutation detected first time area, in
rural settings (1.4%). also identified three classes previously described
mutants frequencies: partially resistant (pfdhfr
51i/59r/108n + pfdhps 437g), found 54% (95% ci 47.75-60.25); fully
resistant (pfdhfr 51i/59r/108n + pfdhps 437g/540e), found 28% (95% ci
7.07-14.93); super resistant (pfdhfr 51i/59r/108n + pfdhps
437g/540e/581g), found 6% (95% ci 0.48-4.32). double mutation pfmdr1
(86y + 1246y) detected 2% (95% ci 0.24-3.76) frequency, distributed in
both urban rural samples. combination single mutations pfmdr1 and
pfcrt genes (86y + 76t), related resistance chloroquine and
amodiaquine, detected 22% (95% ci 16.8-27.2) samples area.
conclusions: high level mutations detected p. falciparum genes related 
to sp resistance could linked unsuccessful withdrawal sp treatment
in area. drug resistance reduce efficacy intermittent
prophylactic treatment sp children 5 years old pregnant
women. although high number mutations detected, efficacy the
first-line treatment, artemisinin/amodiaquine, affected. avoid
increases numbers, occurrence, spread mutations, protect the
population, ministry health ensure health centres and
hospitals supplied appropriate first-line treatments malaria.

doi: 10.1186/s12936-016-1672-0 
pmcid: pmc5237300
pmid: 28086777  [indexed medline]

